Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Amarantus BioScience management update

    Amarantus BioScience Holdings Inc. (OTCQB:AMBS), San Francisco, Calif. Business: Neurology, Cardiovascular Hired: Elise Brownell as SVP of operations and program management, a newly created position

    Published on 12/22/2014
  • Annexon board of directors update

    Annexon Bioscience Inc., Palo Alto, Calif. Business: Neurology, Autoimmune Appointed: Emmett Cunningham, partner at Clarus Ventures; Campbell Murray, managing director at Novartis Venture Funds; and Muneer Satter, …

    Published on 12/22/2014
  • Cristal Therapeutics management update

    Cristal Therapeutics, Maastricht, the Netherlands Business: Autoimmune, Cancer, Drug delivery Transitioned: Cristianne Rijcken to CSO from CEO; she is succeeded by Joost Holthuis, formerly CEO of OctoPlus N.V., which Dr…

    Published on 12/22/2014
  • Genocea management update

    Genocea Biosciences Inc. (NASDAQ:GNCA), Cambridge, Mass. Business: Infectious Hired: Eric Hoffman as CBO, formerly VP of corporate and business development, program management and commercial operations at Idenix …

    Published on 12/22/2014
  • Gilead management update

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Biopharmaceuticals, Infectious, Pulmonary Hired: Philippe Bishop as SVP of hematology and oncology therapeutics, formerly VP of oncology product …

    Published on 12/22/2014
  • Idera management update

    Idera Pharmaceuticals Inc. (NASDAQ:IDRA), Cambridge, Mass. Business: Cancer, Infectious, Autoimmune Hired: J. Peter Wolf as SVP and general counsel, formerly VP, general counsel and secretary at ViroPharma Inc., which …

    Published on 12/22/2014
  • Lion Biotechnologies management update

    Lion Biotechnologies Inc. (OTCQB:LBIO), Woodland Hills, Calif. Business: Cancer Transitioned: Elma Hawkins to CEO, effective Jan. 1, 2015, and director, effective immediately, from COO, while remaining president; she …

    Published on 12/22/2014
  • Merus Labs International management update

    Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Transitioned: Barry Fishman to CEO from interim CEO

    Published on 12/22/2014
  • MonoSol Rx management update

    MonoSol Rx LLC, Warren, N.J. Business: Drug delivery Transitioned: Mark Schobel to chief innovation and technology officer, a newly created position, from CEO; he is succeeded by COO Keith Kendall

    Published on 12/22/2014
  • OvaScience management update

    OvaScience Inc. (NASDAQ:OVAS), Cambridge, Mass. Business: Genitourinary Hired: David Harding as chief commercial officer, formerly group SVP and general manager of womens health at Hologic Inc. Promoted: Theresa McNeely…

    Published on 12/22/2014
  • Proteo management update

    Proteo Inc. (OTCQB:PTEO), Irvine, Calif. Business: Pulmonary, Cardiovascular, Inflammation Hired: Juergen Paal as COO of Proteos Proteo Biotech AG subsidiary, formerly director of business development for therapeutic …

    Published on 12/22/2014
  • Silence Therapeutics management update

    Silence Therapeutics plc (LSE:SLN), London, U.K. Business: Cancer, Renal, Ophthalmic Hired: Lars Karlsson as head of R&D and a director, effective Jan. 5, 2015, formerly VP of autoimmune disease pharmacology at Novo …

    Published on 12/22/2014
  • Takeda management update

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Pharmaceuticals Hired: Andrew Plump as corporate officer, CMO and CSO, effective Feb. 1, 2015, formerly SVP of research and translational medicine and …

    Published on 12/22/2014
  • Vertex management update

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Boston, Mass. Business: Infectious, Autoimmune, Pulmonary Transitioned: David Altshuler to EVP of global research and CSO from a director, effective early 2015, formerly deputy…

    Published on 12/22/2014
  • Zealand Pharma management update

    Zealand Pharma A/S (CSE:ZEAL), Glostrup, Denmark Business: Endocrine/Metabolic, Cardiovascular, Gastrointestinal Departed: Arvind Hundal as SVP and CBO

    Published on 12/22/2014
  • Advanced Cell Diagnostics management update

    Advanced Cell Diagnostics Inc., Hayward, Calif. Business: Diagnostic Hired: Tom Olenic as chief commercial officer, formerly general manager of the sequencing organization and SVP of commercial operations of the …

    Published on 12/15/2014
  • Apricus Biosciences management update

    Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Business: Drug delivery, Genitourinary, Cancer Hired: Brian Dorsey as chief development officer, a newly created position, formerly SVP of pharmaceutical …

    Published on 12/15/2014
  • Asceneuron board of directors update

    Asceneuron S.A., Geneva, Switzerland Business: Neurology Appointed: Raymond Hill, formerly executive director of European licensing and external research at Merck & Co. Inc.

    Published on 12/15/2014
  • Bellicum management update

    Bellicum Pharmaceuticals Inc., Houston, Texas Business: Cancer Hired: Peter Hoang as SVP of business development and strategy, formerly headed the new venture formation and development effort at University of Texas MD …

    Published on 12/15/2014
  • FlowMetric management update

    FlowMetric Inc., Doylestown, Pa. Business: Supply/Service, Diagnostic Hired: Amy Williams as president and a director of FlowMetrics affiliate company, FlowMetric Diagnostics Inc., effective Sept. 1, formerly president …

    Published on 12/15/2014
  • Foundation Medicine management update

    Foundation Medicine Inc. (NASDAQ:FMI), Cambridge, Mass. Business: Diagnostic, Pharmacogenetics Hired: David Daly as chief commercial officer, formerly VP of commercial operations in the anatomic pathology division at …

    Published on 12/15/2014
  • Innocoll management update

    Innocoll GmbH (NASDAQ:INNL), Athlone, Ireland Business: Drug delivery, Neurology, Infectious Hired: Tony Zook as CEO, formerly EVP of global commercial operations at AstraZeneca plc; he succeeds Michael Myers, who …

    Published on 12/15/2014
  • Lannett management update

    Lannett Co. Inc. (NYSE:LCI), Philadelphia, Pa. Business: Generics Hired: Michael Bogda as president, formerly EVP of Americas technical operations at Teva Pharmaceutical Industries Ltd.; he succeeds Arthur Bedrosian, …

    Published on 12/15/2014
  • Merck management update

    Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Pharmaceuticals Transitioned: Jacques Cholat, VP of global vaccines marketing and commercial operations, to interim president of Merck Vaccines; and Julie …

    Published on 12/15/2014
  • Neogen management update

    Neogen Corp. (NASDAQ:NEOG), Lansing, Mich. Business: Diagnostic, Veterinary Hired: Richard Calk as president and COO, formerly VP of chemicals at Nexeo Solutions LLC; he succeeds Steve Snyder

    Published on 12/15/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993